CHROMA: Clinical Trial of Lampalizumab for Geographic Atrophy Secondary to Age-Related Macular Degeneration
FOVISTA NR: Clinical Trial for neovascular age-related macular degeneration
LITE: Development of Advanced Laser Imaging Techniques for the anterior and posterior Eye
FOVISTA: Clinical Trial for subfoveal neovascular age-related macular degeneration
Clinical trial in antiretroviral-naive patients with choroidal neovascularization secondary to AMD
Phase III Study of Lampalizumab in patients with geographic atrophy secondary to AMD
MPL4 GA: A phase I study in subjects with geographic atrophy secondary to dry age-related macular degeneration
Oral Omega 3 GA. A phase II in subjects with geographic atrophy secondary to AMD
A delphi study to detect deficiencies and propose actions in real life treatment of neovascular age-related macular degeneration.
Sustained delivery fluocinolone acetonide vitreous implants: long-term benefit in patients with chronic diabetic macular edema.
Ranibizumab in retinal vein occlusion: treatment recommendations by an expert panel.
Effect of pegaptanib sodium 0.3 mg intravitreal injections (Macugen) in intraocular pressure: posthoc analysis from V.I.S.I.O.N. study.
Reappraisal of geographic atrophy patterns seen on fundus autofluorescence using a latent class analysis approach.
Prospective, randomised, placebo-controlled, double-masked, three-armed, multicenter Phase II/III trial to establish the safety and efficacy of a topical treatment of Neovascular Glaucoma
JETREA M-13-056 Assessment of anatomical and functional outcomes in patients treated with ocriplasmin for vitreomacular traction/symptomatic vitreomacular adhesion